Search Results for:Bhuma Shrivastava

Bain-backed consortium said to be highest bidder for India’s Binani Cement

The Bain Capital-backed Dalmia Bharat consortium made a final offer of more than 63 billion rupees ($981 million) for Binani Cement.


TPG-backed consortium said to bid $1b for Tata Group’s fiber arm

The consortium is led by Mukund Rajan, the head of international operations for Tata Group’s holding company.


Hindalco among potential buyers to bid for $2.5b aluminum producer Aleris

Mumbai-listed Hindalco made a non-binding offer through its U.S. unit, Novelis.


India: L&T may sell some assets by March to fund acquisition spree

Schneider Electric is said to be in exclusive talks to buy the electrical unit, valuing it at around $2 billion.


India: Tata hiring bankers to sell or merge dozens of units

As many as one-third of the group’s 100-plus units could go.


Ambani edges out Li Ka-shing as Asia’s second richest as debt fuels Reliance growth

The Reliance Industries chairman has added $12.1 billion to his wealth this year.


Anil Ambani goes on asset sale spree as lenders ramp up pressure

Ambani aims to raise over $4.5 billion this year to reduce group debt.


India’s $1.3t housing bonanza draws Piramal loan bet

Indian billionaire Ajay Piramal wants to sell mortgages and build affordable homes as the drugs-to-data conglomerate seeks to ride an estimated $1.3 trillion housing-investment boom. Prime Minister Narendra Modi’s government is putting a “huge emphasis” on affordable housing to drive job creation and economic growth, said Piramal, chairman of Piramal… Read more »


India: Aditya Birla Nuvo shareholders approve Grasim merger plan

Shareholders of Aditya Birla Nuvo Ltd, controlled by billionaire Kumar Mangalam Birla, approved plans for a merger with Grasim Industries Ltd that would create a firm with $9 billion in combined revenue. About 83% of ABNL minority shareholder votes cast were in favour of a proposal to merge with affiliate… Read more »


India: Ajay Piramal mulls IPOs for two units to boost market value of group

Piramal, 61, who sold his branded generic drugs unit to Abbott Laboratories for $3.8 billion in 2010, seeks to boost market value of the group by revamping his companies and spinning off businesses housed in his flagship Piramal Enterprises Ltd. “We will look at unlocking value through listings,” Piramal said.